Testosterone Undeconate (Nebido, BAY86-5037) + Placebo
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Hypogonadism
Conditions
Hypogonadism
Trial Timeline
Sep 1, 2010 → Jul 1, 2011
NCT ID
NCT01092858About Testosterone Undeconate (Nebido, BAY86-5037) + Placebo
Testosterone Undeconate (Nebido, BAY86-5037) + Placebo is a approved stage product being developed by Bayer for Hypogonadism. The current trial status is terminated. This product is registered under clinical trial identifier NCT01092858. Target conditions include Hypogonadism.
What happened to similar drugs?
5 of 18 similar drugs in Hypogonadism were approved
Approved (5) Terminated (2) Active (12)
Hype Score Breakdown
Clinical
20
Activity
0
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01092858 | Approved | Terminated |
Competing Products
20 competing products in Hypogonadism